Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: COR

Cencora, Inc.

Healthcare | Medical - Distribution

Market prices for COR are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$13.47

Cencora, Inc. (NYSE: COR) is a medical distributor. Figures from SEC EDGAR; updated 2026-10-21 13:40 UTC.

What Cencora, Inc. does

The company operates in pharmaceutical distribution, competing with other distributors, drug manufacturers, retail pharmacies, and healthcare technology companies. The pharmaceutical and healthcare industries are undergoing consolidation through strategic alliances, which may reduce the company's negotiating power and create competitive pressures. The company extends credit to customers for purchases of pharmaceuticals and other products, with exposure concentrated among major customers and suppliers whose financial instability could materially harm revenues and operations.

Summarized from Cencora, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$13.47
Return on equity103.06%
Debt/equity3.93

Revenue, margins & earnings

FY2021 Operating expenses: $4.59BFY2021 Cost of revenue: $207.0B$214.0BFY2021FY2022 Operating expenses: $5.93BFY2022 Cost of revenue: $230.3B$238.6BFY2022FY2023 Operating expenses: $6.62BFY2023 Cost of revenue: $253.2B$262.2BFY2023FY2024 Operating expenses: $7.73BFY2024 Cost of revenue: $284.0B$294.0BFY2024FY2025 Operating expenses: $8.85BFY2025 Cost of revenue: $309.9B$321.3BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-05
  • 2026-10-05SVP & Chief Accounting OfficerSale-986$298.9K
  • 2026-10-05DirectorAward275—
  • 2026-09-17DirectorSale-1,280$411.3K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Cencora, Inc. do?

The company operates in pharmaceutical distribution, competing with other distributors, drug manufacturers, retail pharmacies, and healthcare technology companies.

When did COR last file with the SEC?

Cencora, Inc.'s most recent SEC filing on record is a 8-K filed 2026-09-25. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 13:40 UTC. This page is also available as JSON at /api/data?ticker=COR and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for COR and 5,000+ tickers.

Create a free account — keep COR
For your agent
GET /api/data?ticker=COR

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt